Formoterol Fumarate 12 mcg (Foradil Aerolizer)

DRUG2 trials

Sponsors

Pearl Therapeutics, Inc., Centre Hospitalier Universitaire, Amiens

Conditions

Chronic Obstructive Pulmonary DiseasePostoperative Pulmonary Complications (PPCs)Thoracic Surgery

Phase 1

Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00880490

Pearl Therapeutics, Inc.Chronic Obstructive Pulmonary Disease

Start: 2008-11-30End: 2009-05-31Updated: 2010-10-13

Unknown Phase

Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary Complications

RecruitingNCT06865040

Centre Hospitalier Universitaire, AmiensPostoperative Pulmonary Complications (PPCs), Thoracic Surgery

Start: 2025-07-31End: 2028-09-01Target: 266Updated: 2026-01-16

Related Papers

A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD.

2014-07-0310 citations